Atherosclerotic Cardiovascular Disease in HIV: Special Focus on Transgender and Cisgender Women
Mabel Toribio, MD, PhD
Instructor in Medicine
Massachusetts General Hospital
Boston MA
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2020. All rights reserved.
Mabel Toribio is an Instructor in Medicine at Harvard Medical School and a clinical investigator at Massachusetts General Hospital (MGH.) She received her MD from Johns Hopkins University School of Medicine. After finishing her internal medicine training at the University of California, San Francisco, she completed her Endocrinology training at MGH. Dr. Toribio's research focuses on HIV-associated cardiometabolic disease with a specific focus on transgender populations. She is dedicated to training students from underrepresented backgrounds in medicine.
At the completion of this educational session, learners will:
- To describe mechanisms of heightened atherosclerotic cardiovascular disease among people living with HIV.
- To discuss prevention and treatment strategies under investigation to mitigate atherosclerotic cardiovascular disease.
- To describe specific populations, i.e. transgender and cisgender women living with HIV, that may be at high risk for cardiovascular
disease.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation
Download Article PDF/Slides